Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
pILIT: Intralymphatic Immunotherapy for Allergic Rhinitis
NCT02301884Phase 1Completed
- Sponsor
- Gachon University Gil Medical Center
- Start
- Nov 2013
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of alutard-sq in allergic rhinitis (AR), sponsored by Gachon University Gil Medical Center. Primary endpoint: Rhinoconjunctivitis Quality of Life Questionnaire at 4 months. Started Nov 2013; status: completed.
02
Drugs
alutard-sq
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02301884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02301884.